Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Repressor Proteins | 11 | 2016 | 249 | 2.980 |
Why?
|
| Granulosa Cells | 8 | 2022 | 42 | 2.520 |
Why?
|
| Ovarian Follicle | 4 | 2017 | 35 | 1.310 |
Why?
|
| Endometriosis | 3 | 2023 | 73 | 1.280 |
Why?
|
| Apoptosis | 9 | 2019 | 1398 | 1.240 |
Why?
|
| Gonadotropins | 5 | 2022 | 27 | 1.030 |
Why?
|
| Signal Transduction | 7 | 2023 | 1908 | 0.990 |
Why?
|
| Mitochondria | 8 | 2016 | 487 | 0.950 |
Why?
|
| MicroRNAs | 7 | 2023 | 426 | 0.880 |
Why?
|
| Cell Differentiation | 10 | 2016 | 587 | 0.870 |
Why?
|
| Curcumin | 2 | 2023 | 74 | 0.820 |
Why?
|
| Neuregulin-1 | 2 | 2022 | 23 | 0.810 |
Why?
|
| Uterine Neoplasms | 1 | 2022 | 39 | 0.790 |
Why?
|
| Leiomyoma | 1 | 2022 | 30 | 0.790 |
Why?
|
| Stromal Cells | 2 | 2018 | 49 | 0.780 |
Why?
|
| Endometrium | 2 | 2023 | 60 | 0.660 |
Why?
|
| Cell Survival | 4 | 2017 | 864 | 0.640 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 121 | 0.600 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2016 | 43 | 0.540 |
Why?
|
| Staurosporine | 3 | 2017 | 38 | 0.520 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 127 | 0.500 |
Why?
|
| Exosomes | 1 | 2016 | 101 | 0.480 |
Why?
|
| Ovary | 4 | 2017 | 108 | 0.470 |
Why?
|
| Caspase 3 | 7 | 2022 | 207 | 0.470 |
Why?
|
| Infertility, Female | 1 | 2014 | 24 | 0.470 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 88 | 0.470 |
Why?
|
| Female | 20 | 2023 | 20969 | 0.460 |
Why?
|
| Adipocytes | 2 | 2012 | 58 | 0.460 |
Why?
|
| Malaria | 2 | 2023 | 78 | 0.420 |
Why?
|
| Gene Silencing | 2 | 2012 | 151 | 0.390 |
Why?
|
| Animals | 23 | 2022 | 15081 | 0.390 |
Why?
|
| Rats | 9 | 2022 | 3483 | 0.390 |
Why?
|
| Biomedical Research | 3 | 2023 | 400 | 0.390 |
Why?
|
| Ceramides | 1 | 2011 | 42 | 0.390 |
Why?
|
| Cytokines | 4 | 2023 | 602 | 0.370 |
Why?
|
| Humans | 27 | 2023 | 37093 | 0.350 |
Why?
|
| Spermatogenesis | 5 | 2011 | 155 | 0.330 |
Why?
|
| Carcinoma, Papillary | 1 | 2008 | 11 | 0.320 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2008 | 18 | 0.320 |
Why?
|
| Stem Cells | 3 | 2022 | 141 | 0.310 |
Why?
|
| Spermatozoa | 3 | 2007 | 200 | 0.310 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 433 | 0.310 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1015 | 0.310 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2017 | 1618 | 0.310 |
Why?
|
| Chlamydia Infections | 2 | 2020 | 196 | 0.300 |
Why?
|
| Follicular Atresia | 2 | 2022 | 6 | 0.300 |
Why?
|
| Organizational Policy | 2 | 2019 | 22 | 0.290 |
Why?
|
| Cell Cycle | 1 | 2008 | 326 | 0.280 |
Why?
|
| bcl-X Protein | 2 | 2017 | 27 | 0.270 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2016 | 286 | 0.270 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 409 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2017 | 152 | 0.250 |
Why?
|
| Adenoviridae | 3 | 2011 | 62 | 0.250 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 312 | 0.240 |
Why?
|
| Neoplasms | 1 | 2014 | 1103 | 0.230 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 37 | 0.210 |
Why?
|
| Sp1 Transcription Factor | 3 | 2008 | 48 | 0.210 |
Why?
|
| Myometrium | 1 | 2022 | 13 | 0.210 |
Why?
|
| Chlamydia | 2 | 2020 | 42 | 0.210 |
Why?
|
| Mentors | 2 | 2023 | 127 | 0.210 |
Why?
|
| Organoids | 1 | 2022 | 22 | 0.210 |
Why?
|
| Cytochromes c | 3 | 2013 | 53 | 0.200 |
Why?
|
| Cells, Cultured | 6 | 2016 | 1518 | 0.200 |
Why?
|
| Anemia, Sickle Cell | 1 | 2023 | 183 | 0.200 |
Why?
|
| Inflammation | 3 | 2023 | 618 | 0.200 |
Why?
|
| Phosphorylation | 2 | 2016 | 928 | 0.190 |
Why?
|
| Toll-Like Receptors | 1 | 2021 | 51 | 0.190 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 803 | 0.190 |
Why?
|
| Estrogens | 1 | 2022 | 202 | 0.190 |
Why?
|
| Embryo, Mammalian | 3 | 2005 | 153 | 0.180 |
Why?
|
| Proteins | 1 | 2003 | 369 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 269 | 0.180 |
Why?
|
| NF-kappa B | 2 | 2023 | 339 | 0.180 |
Why?
|
| Genitalia | 1 | 2019 | 17 | 0.170 |
Why?
|
| Palmitic Acid | 1 | 2019 | 24 | 0.170 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2019 | 28 | 0.170 |
Why?
|
| Peer Review, Research | 1 | 2018 | 10 | 0.170 |
Why?
|
| Leadership | 1 | 2019 | 76 | 0.160 |
Why?
|
| Research Support as Topic | 1 | 2018 | 80 | 0.160 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 225 | 0.160 |
Why?
|
| Follicular Fluid | 1 | 2017 | 4 | 0.150 |
Why?
|
| Theca Cells | 1 | 2017 | 4 | 0.150 |
Why?
|
| Receptor, erbB-3 | 1 | 2017 | 12 | 0.150 |
Why?
|
| Cell Line | 4 | 2019 | 1354 | 0.150 |
Why?
|
| Endothelial Cells | 4 | 2023 | 308 | 0.150 |
Why?
|
| Culture Media | 2 | 2016 | 90 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2011 | 859 | 0.150 |
Why?
|
| Mice | 9 | 2020 | 5913 | 0.150 |
Why?
|
| Research Personnel | 1 | 2018 | 155 | 0.150 |
Why?
|
| Gene Expression | 3 | 2011 | 674 | 0.150 |
Why?
|
| Trypanosomiasis, African | 2 | 2009 | 23 | 0.140 |
Why?
|
| Protein Kinase C | 1 | 2017 | 120 | 0.140 |
Why?
|
| Phosphoproteins | 1 | 2017 | 163 | 0.140 |
Why?
|
| Receptor, erbB-2 | 1 | 2017 | 133 | 0.140 |
Why?
|
| Adult Stem Cells | 1 | 2016 | 12 | 0.140 |
Why?
|
| Autocrine Communication | 1 | 2016 | 12 | 0.140 |
Why?
|
| Steroids | 1 | 2016 | 43 | 0.130 |
Why?
|
| Epithelial Cells | 1 | 2019 | 384 | 0.130 |
Why?
|
| Trypanosoma brucei brucei | 2 | 2009 | 83 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 73 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 173 | 0.130 |
Why?
|
| Testosterone | 1 | 2016 | 193 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2016 | 177 | 0.120 |
Why?
|
| Genital Neoplasms, Female | 1 | 2014 | 11 | 0.120 |
Why?
|
| Hemolysis | 2 | 2023 | 40 | 0.110 |
Why?
|
| Heme | 2 | 2023 | 70 | 0.110 |
Why?
|
| Cultural Diversity | 1 | 2014 | 169 | 0.110 |
Why?
|
| United States | 3 | 2023 | 4223 | 0.110 |
Why?
|
| 3T3-L1 Cells | 1 | 2012 | 16 | 0.100 |
Why?
|
| Oligonucleotides | 1 | 2012 | 49 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 169 | 0.100 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 77 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 146 | 0.100 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2011 | 10 | 0.100 |
Why?
|
| Retinoid X Receptors | 1 | 2011 | 11 | 0.100 |
Why?
|
| Culture Media, Serum-Free | 1 | 2011 | 45 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 218 | 0.100 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2011 | 13 | 0.100 |
Why?
|
| Transfection | 3 | 2008 | 523 | 0.100 |
Why?
|
| Androgens | 1 | 2012 | 89 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2009 | 168 | 0.100 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2008 | 62 | 0.100 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 175 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2023 | 356 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 142 | 0.090 |
Why?
|
| Genetic Vectors | 2 | 2008 | 158 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 2 | 2008 | 252 | 0.090 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2009 | 16 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 461 | 0.080 |
Why?
|
| Adult | 2 | 2016 | 11712 | 0.080 |
Why?
|
| Antigens, Protozoan | 1 | 2009 | 72 | 0.080 |
Why?
|
| Sp3 Transcription Factor | 1 | 2008 | 8 | 0.080 |
Why?
|
| Vibrio cholerae | 1 | 2009 | 98 | 0.080 |
Why?
|
| Brain | 2 | 2008 | 1346 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 2 | 2008 | 515 | 0.080 |
Why?
|
| Ki-67 Antigen | 1 | 2008 | 33 | 0.080 |
Why?
|
| G1 Phase | 1 | 2008 | 33 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1039 | 0.080 |
Why?
|
| Erythrocytes | 1 | 2008 | 111 | 0.080 |
Why?
|
| Neuroglia | 1 | 2008 | 124 | 0.080 |
Why?
|
| Plasmodium falciparum | 1 | 2008 | 135 | 0.070 |
Why?
|
| Phosphatidylserines | 1 | 2006 | 21 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 237 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 515 | 0.070 |
Why?
|
| Time Factors | 1 | 2011 | 1742 | 0.070 |
Why?
|
| Blood Proteins | 1 | 2006 | 66 | 0.070 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2006 | 84 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2008 | 222 | 0.070 |
Why?
|
| Adipogenesis | 1 | 2005 | 12 | 0.070 |
Why?
|
| Lentivirus | 1 | 2005 | 21 | 0.070 |
Why?
|
| Genetic Engineering | 1 | 2005 | 33 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2008 | 513 | 0.060 |
Why?
|
| Cloning, Organism | 1 | 2004 | 22 | 0.060 |
Why?
|
| Hemopexin | 1 | 2023 | 2 | 0.060 |
Why?
|
| Fertilization in Vitro | 1 | 2004 | 54 | 0.060 |
Why?
|
| 14-3-3 Proteins | 1 | 2023 | 22 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2004 | 207 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 1609 | 0.060 |
Why?
|
| Oocytes | 1 | 2004 | 146 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 62 | 0.060 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2003 | 34 | 0.060 |
Why?
|
| Epididymis | 1 | 2003 | 28 | 0.060 |
Why?
|
| Fertilization | 1 | 2003 | 38 | 0.060 |
Why?
|
| Liposomes | 1 | 2023 | 118 | 0.050 |
Why?
|
| Plasmodium | 1 | 2022 | 14 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2003 | 78 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 807 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 211 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2004 | 387 | 0.050 |
Why?
|
| Protozoan Proteins | 1 | 2004 | 182 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 149 | 0.050 |
Why?
|
| Chemokines | 1 | 2022 | 97 | 0.050 |
Why?
|
| Cattle | 1 | 2003 | 477 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 2231 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 893 | 0.050 |
Why?
|
| Male | 7 | 2016 | 20025 | 0.050 |
Why?
|
| Pregnancy, Ectopic | 1 | 2020 | 14 | 0.050 |
Why?
|
| Photoperiod | 1 | 2020 | 26 | 0.050 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2020 | 19 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2021 | 149 | 0.040 |
Why?
|
| Chlamydia muridarum | 1 | 2020 | 104 | 0.040 |
Why?
|
| Writing | 1 | 2018 | 37 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 164 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 1371 | 0.040 |
Why?
|
| Base Sequence | 2 | 2011 | 997 | 0.040 |
Why?
|
| Program Development | 1 | 2018 | 233 | 0.040 |
Why?
|
| Transcriptional Activation | 2 | 2008 | 172 | 0.040 |
Why?
|
| Computational Biology | 1 | 2019 | 293 | 0.040 |
Why?
|
| Cell-Derived Microparticles | 1 | 2016 | 7 | 0.030 |
Why?
|
| Isoenzymes | 2 | 2008 | 161 | 0.030 |
Why?
|
| Microvessels | 1 | 2016 | 28 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 84 | 0.030 |
Why?
|
| Pregnancy | 1 | 2020 | 1549 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 626 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2009 | 661 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 337 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 1568 | 0.030 |
Why?
|
| Minority Groups | 1 | 2019 | 596 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 623 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2009 | 1207 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 571 | 0.030 |
Why?
|
| DNA Primers | 1 | 2011 | 286 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 306 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 448 | 0.020 |
Why?
|
| Protozoan Vaccines | 1 | 2009 | 15 | 0.020 |
Why?
|
| Antibodies, Protozoan | 1 | 2009 | 79 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 91 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2008 | 136 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2008 | 162 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2007 | 85 | 0.020 |
Why?
|
| Binding Sites | 1 | 2008 | 651 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2008 | 474 | 0.020 |
Why?
|
| Teratoma | 1 | 2005 | 9 | 0.020 |
Why?
|
| Regeneration | 1 | 2005 | 20 | 0.020 |
Why?
|
| Transgenes | 1 | 2005 | 59 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 578 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2005 | 50 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2005 | 76 | 0.020 |
Why?
|
| Cell Separation | 1 | 2005 | 93 | 0.020 |
Why?
|
| Seminiferous Tubules | 1 | 2004 | 8 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2005 | 172 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 129 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2004 | 150 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 54 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 208 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 1180 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 325 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 399 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 133 | 0.010 |
Why?
|
| Endopeptidases | 1 | 2004 | 59 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 92 | 0.010 |
Why?
|
| Cerebellum | 1 | 2004 | 73 | 0.010 |
Why?
|
| Brain Stem | 1 | 2004 | 50 | 0.010 |
Why?
|
| Mutation | 1 | 2008 | 1095 | 0.010 |
Why?
|
| Caspases | 1 | 2004 | 147 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2004 | 102 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2005 | 166 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 286 | 0.010 |
Why?
|